Prospective Randomized Endovascular Therapy in Multiple Sclerosis
Part of paid clinical trials in Buffalo, New York.
- Sponsor
- University at Buffalo
- Study ID
- NCT05380362
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Venous Angioplasty — OTHERvenous angiogram to look for lesions or flaps and then plastying vessels open.
- Sham Angioplasty — OTHERPatients will be brought to the angio suite and will not know if they are having the venous angioplasty or not.
Study Details
1. To assess the safety of endovascular therapy (balloon angioplasty) for venous stenoses in MS patients with CCSVI as documented by sonographic (extracranial echocolor-Doppler (ECD) and transcranial color Doppler (TCD) 2. To study the morphology of the venous anomalies by using intraluminal ultrasound (IVUS). 3. To evaluate preliminary efficacy of endovascular therapy (angioplasty) as measured by clinical (relapse rate, disability progression (EDSS)), sonographic (ECD/TCD) and MRI/MRV parameters. 4. To evaluate change in patients self-reported QOL following the therapeutic angioplasty 5. To evaluate whether changes in QOL, fatigue, MSFC or attention following therapeutic angioplasty are associated with brain changes as measured by functional MRI (fMRI).
Key Dates
- Start date
- Jun 30, 2010
- Status verified
- Aug 2025
- Primary completion
- Apr 30, 2013
- Completion
- Apr 30, 2013
Study Design
- Enrollment
- 30 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Venous Angioplasty20 patients will have venous angio plasty
- Sham Comparator: Angio with no plastyPatients will be brought to the angio suite and given and angio but no plasty although patient will not be aware of which treatment they are having.
Primary Outcome Measure
Percentage of Patients With Immediate and Short-term SAE [ Time Frame: 1 month post-procedure ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Gates Circle Hospital | Buffalo | New York | 14209 | - |
Find similar trials in Buffalo, NY
Related Studies
- Genes and Environment in Multiple SclerosisRecruiting · Columbia University · Bethesda, Maryland
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPHASE4 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · New Haven, Connecticut
- Vancomycin Study in Multiple Sclerosis (MS)PHASE1 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York